Free Trial

Benitec Biopharma (BNTC) Earnings Date, Estimates & Call Transcripts

Benitec Biopharma logo
$13.93 -0.05 (-0.36%)
As of 05/20/2025 04:00 PM Eastern

Benitec Biopharma Earnings Summary

Benitec Biopharma announced Q3 2025 earnings on May 14, 2025, reporting an EPS of -$0.24, which beat analysts' consensus estimates of -$0.36 by $0.12. With a trailing EPS of -$1.51, Benitec Biopharma's earnings are expected to decrease next year, from ($1.48) to ($2.31) per share.

Q3 2025 Earnings Resources

Latest Q3 2025
Earnings Date
May. 14Estimated
Consensus EPS
(May. 14)
-$0.36
Actual EPS
(May. 14)
-$0.24 Beat By $0.12
Get Benitec Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Benitec Biopharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BNTC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BNTC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Benitec Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.54-$0.54-$0.54
Q2 20252-$0.34-$0.27-$0.31
Q3 20252-$0.31-$0.26-$0.29
Q4 20252-$0.34-$0.26-$0.30

Benitec Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2025Q3 2025-$0.36-$0.24+$0.12-$0.24--
2/14/2025Q2 2025-$0.55-$0.36+$0.19-$0.33--
5/13/2024Q3 2024--$1.64 -$1.64-$1.64--
2/13/2024Q2 2024--$2.64 -$2.64-$2.64--
11/13/2023Q1 2024--$2.76 -$2.76-$2.76--

Benitec Biopharma Earnings - Frequently Asked Questions

Benitec Biopharma (NASDAQ:BNTC) last announced its quarterly earning data on Wednesday, May 14, 2025. Learn more on BNTC's earnings history.

In the previous quarter, Benitec Biopharma (NASDAQ:BNTC) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.36) by $0.12. Learn more on analysts' earnings estimate vs. BNTC's actual earnings.

Benitec Biopharma (NASDAQ:BNTC) has a recorded annual revenue of $80,000.00.

Benitec Biopharma (NASDAQ:BNTC) has a recorded net income of -$21.75 million. BNTC has generated -$1.51 earnings per share over the last four quarters.

Benitec Biopharma's earnings are expected to decrease from ($1.48) per share to ($2.31) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BNTC) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners